Published in Am J Med Sci on April 28, 1979
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med (1987) 5.74
Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med (1993) 4.72
Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation (1998) 4.56
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis (2001) 4.01
Group C streptococcal bacteremia: analysis of 88 cases. Rev Infect Dis (1991) 3.88
Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med (1994) 3.32
Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med (1991) 3.03
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78
NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Am J Med (1994) 2.60
Use of a colorimetric system for yeast susceptibility testing. J Clin Microbiol (1995) 2.54
The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis (2001) 2.25
Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med (1996) 2.15
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis (2007) 2.09
Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin Infect Dis (1996) 2.09
Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America. Clin Infect Dis (2000) 2.08
Alopecia associated with fluconazole therapy. Ann Intern Med (1995) 2.05
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med (1992) 2.01
Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin. Infect Control Hosp Epidemiol (1990) 1.90
Single-concentration broth microdilution test for detection of high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1987) 1.85
Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates. Antimicrob Agents Chemother (1996) 1.83
Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 1.80
Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA Technical Panel on Infections Within Hospitals. Infect Control Hosp Epidemiol (1994) 1.79
Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119) Hepatology (1991) 1.78
Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol (1988) 1.69
Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test. Clin Pharmacol Ther (1997) 1.64
Gentamicin resistance plasmids of enterococci from diverse geographic areas are heterogeneous. J Infect Dis (1988) 1.60
Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function. J Lab Clin Med (1978) 1.57
Histoplasmosis in immunosuppressed patients. Am J Med (1978) 1.54
The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses (1990) 1.53
Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275. Gastroenterology (1993) 1.52
Purulent pneumococcal pericarditis. A continuing problem in the antibiotic era. Am J Med (1973) 1.51
Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50
High-level aminoglycoside-resistant enterococci. Colonization of nursing home and acute care hospital patients. Arch Intern Med (1987) 1.49
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. Clin Infect Dis (2001) 1.48
Torulopsis glabrata renal infection. Am J Med (1974) 1.48
Increasing resistance of Staphylococcus aureus to ciprofloxacin. Antimicrob Agents Chemother (1990) 1.45
Risk factors for colonization with yeast species in a Veterans Affairs long-term care facility. J Am Geriatr Soc (1998) 1.45
Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med (1995) 1.44
Host response to mycobacterial infection in the alcoholic rat. Gastroenterology (1990) 1.44
Intermittent urethral catheterization in the elderly. J Am Geriatr Soc (1989) 1.43
Detection and characterization of mupirocin resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1993) 1.43
Bone marrow toxicity associated with 5-fluorocytosine therapy. Antimicrob Agents Chemother (1977) 1.42
Group B streptococcal prosthetic joint infection following sigmoidoscopy. Clin Infect Dis (1992) 1.42
Increasing resistance of enterococci to ciprofloxacin. Antimicrob Agents Chemother (1992) 1.40
Treatment of blastomycosis with fluconazole: a pilot study. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1995) 1.37
Emergence of nosocomial methicillin-resistant Staphylococcus aureus and therapy of colonized personnel during a hospital-wide outbreak. Infect Control (1987) 1.36
Cryptococcus laurentii lung abscess. Am Rev Respir Dis (1981) 1.35
Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med (1999) 1.32
Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1999) 1.32
Rapid identification of Staphylococcus aureus by using lysostaphin sensitivity. J Clin Microbiol (1980) 1.30
Enterococcal superinfection in patients treated with ciprofloxacin. J Antimicrob Chemother (1988) 1.29
Colonization and infection with antibiotic-resistant bacteria in a long-term care facility. J Am Geriatr Soc (1994) 1.29
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Cardiobacterium hominis endocarditis: Two cases and a review of the literature. Eur J Clin Microbiol Infect Dis (2006) 1.28
Evaluation of the BACTEC antimicrobial removal system for detection of bacteremia. J Clin Microbiol (1983) 1.27
Alterations in gastric acidity in patients infected with human immunodeficiency virus. Clin Infect Dis (1995) 1.21
Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease. Eur J Clin Microbiol Infect Dis (2008) 1.20
Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia. Mycoses (1999) 1.20
Association of Reye's syndrome with viral infection. Lancet (1974) 1.17
Cellular immune response to cytomegalovirus infection after renal transplantation. Infect Immun (1978) 1.13
Salmonella meningitis. Occurrence in an adult. Arch Neurol (1979) 1.13
Superinfection with Streptococcus pneumoniae during therapy with ciprofloxacin. Am J Med (1990) 1.12
Detection of cryptococcal antigen. Comparison of two latex agglutination tests. Am J Clin Pathol (1981) 1.11
A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology (1993) 1.10
Mupirocin resistance: clinical and molecular epidemiology. Infect Control Hosp Epidemiol (1995) 1.10
Rhodotorula fungaemia: a life-threatening complication of indwelling central venous catheters. Mycoses (1993) 1.10
Outbreak of sternal surgical site infections due to Pseudomonas aeruginosa traced to a scrub nurse with onychomycosis. Clin Infect Dis (2001) 1.10
Trends in species causing fungaemia in a tertiary care medical centre over 12 years. Mycoses (2001) 1.09
Hospital-acquired infective endocarditis. Arch Intern Med (1988) 1.09
Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother (1994) 1.07
Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275. JPEN J Parenter Enteral Nutr (1996) 1.06
Torulopsis glabrata: azole susceptibilities by microdilution colorimetric and macrodilution broth assays. J Clin Microbiol (1995) 1.06
Cell-mediated immunity in patients on long-term haemodialysis. Clin Exp Immunol (1975) 1.06
Simple assay for 5-fluorocytosine in the presence of amphotericin B. Antimicrob Agents Chemother (1976) 1.05
Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis (2001) 1.05
Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. Alcohol Clin Exp Res (1995) 1.05
Recurrent pseudobacteremias traced to a radiometric blood culture device. Infect Control (1987) 1.05
Nosocomial infection with gentamicin-carbenicillin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1976) 1.04
Cryptococcal endophthalmitis: case report and review. Clin Infect Dis (1992) 1.04
Measles immunity after revaccination: results in children vaccinated before 10 months of age. Pediatrics (1982) 1.03
Effect of hand cleansing with antimicrobial soap or alcohol-based gel on microbial colonization of artificial fingernails worn by health care workers. Clin Infect Dis (2001) 1.03
Candidiasis. A diagnostic and therapeutic challenge. Postgrad Med (1986) 1.03
Antimicrobial resistance of Haemophilus species in patients with chronic bronchitis. Am Rev Respir Dis (1979) 1.03
Mucormycosis: association with deferoxamine therapy. Am J Med (1989) 1.02
Colonization with vancomycin-resistant Enterococcus faecium: comparison of a long-term-care unit with an acute-care hospital. Infect Control Hosp Epidemiol (1997) 1.01
Long-term survival of vancomycin-resistant Enterococcus faecium on a contaminated surface. Infect Control Hosp Epidemiol (1996) 1.01
Polymicrobial bacteremia. JAMA (1979) 1.01
Septic arthritis in the elderly. J Am Geriatr Soc (1985) 1.00
Prosthetic joint infections in the elderly. Am J Med (1990) 1.00
Comparative in vitro activity of quinupristin/dalfopristin against multidrug resistant Enterococcus faecium. Diagn Microbiol Infect Dis (1996) 0.99
Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid. Antimicrob Agents Chemother (1985) 0.99
Sex steroid regulation of autoimmunity. J Steroid Biochem Mol Biol (1991) 0.99
Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis (2001) 0.98
Chronic candidal meningitis: an uncommon manifestation of candidiasis. Clin Infect Dis (1994) 0.98
Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to clinafloxacin. Diagn Microbiol Infect Dis (1995) 0.98
Invasive fungal infections in patients with chronic mucocutaneous candidiasis. Arch Intern Med (1981) 0.98
Treatment of sporotrichosis with itraconazole. NIAID Mycoses Study Group. Am J Med (1993) 0.97
Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1997) 0.97
Influenza virus infection of the guinea pig: immune response and resistance. Med Microbiol Immunol (1979) 0.97